285 related articles for article (PubMed ID: 19840019)
1. Management of poor-prognosis or relapsed germ-cell cancer.
Daugaard G
BJU Int; 2009 Nov; 104(9 Pt B):1392-7. PubMed ID: 19840019
[No Abstract] [Full Text] [Related]
2. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
Pizzocaro G; Guarneri A
Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
[No Abstract] [Full Text] [Related]
3. Management of recurrent testicular germ cell tumors.
Sonpavde G; Hutson TE; Roth BJ
Oncologist; 2007 Jan; 12(1):51-61. PubMed ID: 17227900
[TBL] [Abstract][Full Text] [Related]
4. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy in nonseminomatous germ cell cancer.
Kollmannsberger C; Beyer J; Bokemeyer C
BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
[No Abstract] [Full Text] [Related]
6. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B
Urologiia; 2007; (2):58-63. PubMed ID: 17578200
[TBL] [Abstract][Full Text] [Related]
7. Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
Vaughn DJ; Stadtmauer EA
J Clin Oncol; 2007 Jan; 25(3):239-40. PubMed ID: 17235039
[No Abstract] [Full Text] [Related]
8. [Retroperitoneal residual tumor resection after chemotherapy of malignant testicular cancers].
Albers P
Aktuelle Urol; 2012 May; 43(3):197-206. PubMed ID: 22639031
[No Abstract] [Full Text] [Related]
9. High-dose chemotherapy for male germ cell tumor.
Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
[TBL] [Abstract][Full Text] [Related]
10. Postchemotherapy surgery for germ cell tumors of the testis.
Carver BS; Sheinfeld J
Curr Opin Oncol; 2011 May; 23(3):271-4. PubMed ID: 21415749
[TBL] [Abstract][Full Text] [Related]
11. Germ-cell tumors.
De Giorgi U; Pedrazzoli P; Rosti G; ;
N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969230
[No Abstract] [Full Text] [Related]
12. Germ-cell tumors.
Lorch A; Beyer J; Bokemeyer C
N Engl J Med; 2007 Oct; 357(17):1772-3; author reply 1773-4. PubMed ID: 17969228
[No Abstract] [Full Text] [Related]
13. Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy.
Peckham MJ
Prog Clin Biol Res; 1985; 203():523-38. PubMed ID: 2421341
[No Abstract] [Full Text] [Related]
14. Current treatment of high risk testis cancer.
Schmoll HJ; Jordan K
Eur J Cancer; 2009 Sep; 45 Suppl 1():433-5. PubMed ID: 19775661
[No Abstract] [Full Text] [Related]
15. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
Vaughn DJ
Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
[TBL] [Abstract][Full Text] [Related]
16. The Southwest Oncology Group Study for advanced testicular cancer.
Crawford ED
Semin Urol; 1984 Nov; 2(4):244-53. PubMed ID: 6095397
[No Abstract] [Full Text] [Related]
17. Cancer stem cell in relapsed testicular germ cell cancer: embryonic or somatic?
Mego M
Int J Androl; 2006 Dec; 29(6):627. PubMed ID: 17073946
[No Abstract] [Full Text] [Related]
18. Indications and results of surgery after chemotherapy of testicular tumors (NSGT and seminoma).
Donohue JP
Prog Clin Biol Res; 1988; 269():451-9. PubMed ID: 2839850
[No Abstract] [Full Text] [Related]
19. Germ-cell tumors.
Shamash J; Stebbing J; Powles T
N Engl J Med; 2007 Oct; 357(17):1771-2; author reply 1773-4. PubMed ID: 17960020
[No Abstract] [Full Text] [Related]
20. [High dose chemotherapy and germ cell tumor].
Massard C; Fléchon A; Fizazi K; Droz JP
Bull Cancer; 2011 Aug; 98(8):945-9. PubMed ID: 21821481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
